MyMedidata native app to significantly cut study start-up times, improve patient experience

KUALA LUMPUR, Dec 7 (Bernama) -- Medidata, a Dassault Systèmes company, has launched a new patient-centric native myMedidata app to provide trial participants with a seamless platform experience and a single login for all their remote trial activities.

Powered by the new Medidata Designer build tool, the app is capable of significantly cutting study start-up times and is designed with the customer and patient feedback to expand options for electronic clinical outcome assessments (eCOA) and other Decentralized Clinical Trial activities.

The app will feature all of the myMedidata patient-centric solutions, with an initial focus on eCOA. The myMedidata app is available on iOS and Android and can be used both on the patients’ own devices or via a provisioned device.

“Our latest addition to myMedidata brings an innovative app to patients designed in concert with our patient insights team, customer feedback, and the experiences derived from running the world’s biggest DCTs over the last twenty years.

“Medidata is leveraging its unique insights from sponsors, CROs, sites, and patients to make a meaningful difference in the clinical trial experience,” said Matt Noble, the senior vice-president of Medidata Patient Cloud, in a statement.

Unique to the industry, the myMedidata app is unified with the Medidata Platform, including Rave EDC (electronic data capture), resulting in an entirely self-sustaining ecosystem where patient input, site-based activities, and behind-the-scenes data management seamlessly operate together.

The app is configured using Medidata Designer, a new platform configuration tool, bringing a patient-centered mobile-first workflow builder to the myMedidata app.

-- BERNAMA